Table 1 Relationship between SET8 expressions and clinicopathologic features in GC.
Features | N | High expression | Low expression | P | χ2 |
|---|---|---|---|---|---|
All case | 90 | 67 | 23 | ||
90 | |||||
Age | |||||
<55 | 25 | 18 | 7 | 0.742 | 0.109 |
≥55 | 65 | 49 | 16 | ||
Gender | |||||
Male | 53 | 41 | 12 | 0.448 | 0.575 |
Female | 37 | 26 | 11 | ||
Tumor size | |||||
<5 cm | 34 | 28 | 6 | 0.18 | 1.796 |
≥5 cm | 56 | 39 | 17 | ||
Differentiation | |||||
Well-moderate | 21 | 18 | 3 | 0.176 | 1.829 |
Poor | 69 | 49 | 20 | ||
Serosal invasion | |||||
No | 9 | 9 | 0 | 0.064 | 3.433 |
Yes | 81 | 58 | 23 | ||
Vessel invasion | |||||
No | 61 | 48 | 13 | 0.181 | 1.792 |
Yes | 29 | 19 | 10 | ||
Lymphatic metastasis | |||||
No | 23 | 19 | 4 | 0.198 | 1.082 |
Yes | 67 | 48 | 19 | ||
AJCC’s stage | |||||
1 + 2 | 36 | 31 | 5 | 0.038 | 4.293 |
3 + 4 | 54 | 36 | 18 | ||
Remote metastasis | |||||
No | 86 | 66 | 20 | 0.02 | 5.379 |
Yes | 4 | 1 | 3 |
